Immune Design Corp. (IMDZ)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
04-Apr-19 5:15 PM
View: 
Brady Stephen R
EVP, Strategy & Finance
Immune Design Corp. (IMDZ) 02-Apr-19Disposition 17,063$5.85$99,818.50(100%)
17.06K to 0
0%
04-Apr-19 5:14 PM
View: 
Paya Carlos V
President and CEO
Director
Immune Design Corp. (IMDZ) 02-Apr-19Disposition 35,576$5.85$208,120.00(100%)
35.58K to 0
0%
04-Apr-19 5:17 PM
View: 
Baltimore David
Director
Immune Design Corp. (IMDZ) 02-Apr-19Disposition 78,287$5.85$457,979.00(100%)
78.29K to 0
0%
04-Apr-19 5:13 PM
View: 
Ter Meulen Jan Henrik
Chief Scientific Officer
Immune Design Corp. (IMDZ) 02-Apr-19Disposition 14,620$5.85$85,527.00(100%)
14.62K to 0
0%
02-Apr-19 8:57 PM
View: 
Column Group L P
10% Owner
Immune Design Corp. (IMDZ) 02-Apr-19Disposition (change in control) 6,642,940$5.85$38,861,200.00(100%)
6.64M to 0
0%
04-Apr-19 5:14 PM
View: 
Gombotz Wayne
Chief Development Officer
Immune Design Corp. (IMDZ) 02-Apr-19Disposition 37,068----(100%)
37.07K to 0
04-Apr-19 5:06 PM
View: 
Coleman Lewis W
Director
Immune Design Corp. (IMDZ) 02-Apr-19Disposition 178,000$5.85$1,041,300.00(100%)
178.0K to 0
0%
04-Apr-19 5:16 PM
View: 
Yurasov Sergey
Sr. VP, Clinic. Devel. & CMO
Immune Design Corp. (IMDZ) 02-Apr-19Disposition 6,136$5.85$35,895.60(100%)
6.14K to 0
0%
04-Apr-19 5:24 PM
View: 
Berger Franklin M
Director
Immune Design Corp. (IMDZ) 02-Apr-19Disposition 75,000$5.85$438,750.00(100%)
75.0K to 0
0%
07-Jan-19 8:36 PM
View: 
Paya Carlos V
President and CEO
Director
Immune Design Corp. (IMDZ) 07-Jan-19Market Sale (Planned) 13,014$1.58$20,590.80(8%)
169.59K to 156.58K
9%
07-Jan-19 8:35 PM
View: 
Ter Meulen Jan Henrik
Chief Scientific Officer
Immune Design Corp. (IMDZ) 07-Jan-19Market Sale (Planned) 3,414$1.59$5,414.60(4%)
87.4K to 83.98K
9%
07-Jan-19 8:33 PM
View: 
Brady Stephen R
EVP, Strategy & Finance
Immune Design Corp. (IMDZ) 07-Jan-19Market Sale (Planned) 5,516$1.58$8,721.90(5%)
102.11K to 96.6K
9%
07-Jan-19 8:34 PM
View: 
Yurasov Sergey
Sr. VP, Clinic. Devel. & CMO
Immune Design Corp. (IMDZ) 07-Jan-19Market Sale (Planned) 3,522$1.57$5,535.53(4%)
82.28K to 78.76K
8%
07-Jan-19 8:34 PM
View: 
Yurasov Sergey
Sr. VP, Clinic. Devel. & CMO
Immune Design Corp. (IMDZ) 03-Jan-19Grant 25,000----44%
57.28K to 82.28K
07-Jan-19 8:33 PM
View: 
Brady Stephen R
EVP, Strategy & Finance
Immune Design Corp. (IMDZ) 03-Jan-19Grant 25,000----32%
77.11K to 102.11K
07-Jan-19 8:36 PM
View: 
Paya Carlos V
President and CEO
Director
Immune Design Corp. (IMDZ) 03-Jan-19Grant 63,000----59%
106.59K to 169.59K
07-Jan-19 8:35 PM
View: 
Ter Meulen Jan Henrik
Chief Scientific Officer
Immune Design Corp. (IMDZ) 03-Jan-19Grant 25,000----40%
62.4K to 87.4K
04-Dec-18 9:59 PM
View: 
Bvf Partners L P/il
10% Owner
Immune Design Corp. (IMDZ) 04-Dec-18Market Sale 902,000$1.83$1,653,910.00(16%)
5.72M to 4.82M
21%
09-Nov-18 4:13 PM
View: 
Yurasov Sergey
Sr. VP, Clinic. Devel. & CMO
Immune Design Corp. (IMDZ) 07-Nov-18Grant 29,953----110%
27.32K to 57.28K
09-Nov-18 4:14 PM
View: 
Brady Stephen R
EVP, Strategy & Finance
Immune Design Corp. (IMDZ) 07-Nov-18Grant 29,953----64%
47.16K to 77.11K
09-Nov-18 4:15 PM
View: 
Ter Meulen Jan Henrik
Chief Scientific Officer
Immune Design Corp. (IMDZ) 07-Nov-18Grant 23,362----60%
39.03K to 62.4K
08-Jan-18 8:24 PM
View: 
Gombotz Wayne
Chief Development Officer
Immune Design Corp. (IMDZ) 05-Jan-18Market Sale (Planned) 1,986$4.17$8,281.82(5%)
39.05K to 37.07K
65%
08-Jan-18 8:18 PM
View: 
Brady Stephen R
EVP, Strategy & Finance
Immune Design Corp. (IMDZ) 05-Jan-18Market Sale (Planned) 3,328$4.17$13,884.70(7%)
50.49K to 47.16K
65%
08-Jan-18 8:21 PM
View: 
Paya Carlos V
President and CEO
Director
Immune Design Corp. (IMDZ) 05-Jan-18Market Sale (Planned) 7,970$4.17$33,246.90(7%)
114.56K to 106.59K
65%
08-Jan-18 8:19 PM
View: 
Ter Meulen Jan Henrik
Chief Scientific Officer
Immune Design Corp. (IMDZ) 05-Jan-18Market Sale (Planned) 1,986$4.17$8,281.62(5%)
41.02K to 39.03K
65%
08-Jan-18 8:19 PM
View: 
Ter Meulen Jan Henrik
Chief Scientific Officer
Immune Design Corp. (IMDZ) 04-Jan-18Grant 18,000----78%
23.02K to 41.02K
05-Jan-18 6:30 PM
View: 
Yurasov Sergey
Sr. VP, Clinic. Devel. & CMO
Immune Design Corp. (IMDZ) 04-Jan-18Market Sale 675$4.17$2,816.44(2%)
28.0K to 27.32K
65%
08-Jan-18 8:21 PM
View: 
Paya Carlos V
President and CEO
Director
Immune Design Corp. (IMDZ) 04-Jan-18Grant 46,500----68%
68.06K to 114.56K
05-Jan-18 6:30 PM
View: 
Yurasov Sergey
Sr. VP, Clinic. Devel. & CMO
Immune Design Corp. (IMDZ) 04-Jan-18Grant 22,000----367%
6.0K to 28.0K
08-Jan-18 8:24 PM
View: 
Gombotz Wayne
Chief Development Officer
Immune Design Corp. (IMDZ) 04-Jan-18Grant 16,000----69%
23.05K to 39.05K
08-Jan-18 8:18 PM
View: 
Brady Stephen R
EVP, Strategy & Finance
Immune Design Corp. (IMDZ) 04-Jan-18Grant 20,000----66%
30.49K to 50.49K
06-Nov-17 9:15 AM
View: 
Coleman Lewis W
Director
Immune Design Corp. (IMDZ) 02-Nov-17Market Purchase 50,000$4.50$225,000.0039%
128.0K to 178.0K
(68%)
01-Nov-17 6:10 PM
View: 
Berger Franklin M
Director
Immune Design Corp. (IMDZ) 30-Oct-17Market Purchase 25,000$4.57$114,375.0050%
50.0K to 75.0K
(68%)
27-Oct-17 7:40 PM
View: 
Svennilson Peter
Director
10% Owner
Immune Design Corp. (IMDZ) 27-Oct-17Market Purchase
Duplicate
2,681,000$4.10$10,992,100.0068%
3.96M to 6.64M
(65%)
31-Oct-17 7:00 PM
View: 
Coleman Lewis W
Director
Immune Design Corp. (IMDZ) 27-Oct-17Market Purchase 65,000$4.07$264,752.00103%
63.0K to 128.0K
(64%)
30-Oct-17 5:03 PM
View: 
Column Group L P
10% Owner
Immune Design Corp. (IMDZ) 27-Oct-17Market Purchase 2,681,000$4.10$10,992,100.0068%
3.96M to 6.64M
(65%)
26-Oct-17 7:31 PM
View: 
Berger Franklin M
Director
Immune Design Corp. (IMDZ) 25-Oct-17Market Purchase 25,000$4.26$106,620.00100%
25.0K to 50.0K
(66%)
03-Aug-17 5:06 PM
View: 
Gombotz Wayne
Chief Development Officer
Immune Design Corp. (IMDZ) 01-Aug-17Option Exercise 10,000$1.31$13,100.0043%
23.05K to 33.05K
03-Aug-17 5:06 PM
View: 
Gombotz Wayne
Chief Development Officer
Immune Design Corp. (IMDZ) 01-Aug-17Market Option Sale (Planned) 10,000$11.43$114,336.00(30%)
33.05K to 23.05K
87%
12-Jul-17 6:08 PM
View: 
Coleman Lewis W
Director
Immune Design Corp. (IMDZ) 11-Jul-17Market Purchase 2,000$9.32$18,650.003%
61.0K to 63.0K
(84%)
12-Jul-17 6:08 PM
View: 
Coleman Lewis W
Director
Immune Design Corp. (IMDZ) 10-Jul-17Market Purchase 10,000$8.99$89,950.0020%
51.0K to 61.0K
(84%)
10-Jul-17 7:03 PM
View: 
Coleman Lewis W
Director
Immune Design Corp. (IMDZ) 07-Jul-17Market Purchase 4,000$9.15$36,600.009%
47.0K to 51.0K
(84%)
10-Jul-17 7:03 PM
View: 
Coleman Lewis W
Director
Immune Design Corp. (IMDZ) 06-Jul-17Market Purchase 4,000$9.39$37,550.009%
43.0K to 47.0K
(85%)
22-May-17 7:40 PM
View: 
Guthart Leo
10% Owner
Immune Design Corp. (IMDZ) 10-May-17Market Purchase 5,000$6.14$30,700.00< 1%
3.12M to 3.13M
(76%)
22-May-17 7:40 PM
View: 
Guthart Leo
10% Owner
Immune Design Corp. (IMDZ) 09-May-17Market Purchase 25,000$6.08$151,906.00< 1%
3.1M to 3.12M
(76%)
06-Jan-17 9:32 PM
View: 
Paya Carlos V
President and CEO
Director
Immune Design Corp. (IMDZ) 04-Jan-17Market Sale (Planned) 3,940$5.35$21,079.00(5%)
72.0K to 68.06K
73%
06-Jan-17 9:35 PM
View: 
Gombotz Wayne
Chief Development Officer
Immune Design Corp. (IMDZ) 04-Jan-17Market Sale (Planned) 980$5.35$5,243.00(4%)
24.03K to 23.05K
73%
06-Jan-17 8:51 PM
View: 
Yurasov Sergey
Sr. VP, Clinic. Devel. & CMO
Immune Design Corp. (IMDZ) 04-Jan-17Grant 6,000----100%
0 to 6.0K
06-Jan-17 9:36 PM
View: 
Ter Meulen Jan Henrik
Chief Scientific Officer
Immune Design Corp. (IMDZ) 04-Jan-17Market Sale (Planned) 980$5.35$5,243.00(4%)
24.0K to 23.02K
73%
06-Jan-17 9:35 PM
View: 
Gombotz Wayne
Chief Development Officer
Immune Design Corp. (IMDZ) 04-Jan-17Grant 12,000----100%
12.03K to 24.03K